Todd Demmy, MD, FACS

Thomas Schwaab, MD, PhD

Roswell Park Cancer Institute
Chief of Strategy, Business Development and Outreach
Associate Professor of Oncology
Department of Urology
Department of Immunology

Thomas Schwaab, MD, PhD, is Roswell Park's Chief of Strategy, Business Development and Outreach. Dr. Schwaab, an Associate Professor of Oncology and Immunology, joined the Institute’s faculty in 2009. In his new role, Dr. Schwaab supervises RPCI’s business development and overall strategic development. He assures that business and clinical initiatives are delivered appropriately and support maximal quality, efficiency and effectiveness, and works to continually widen the Institute’s scope of operations and growth potential at national and international levels.

Areas of Expertise: 
Bladder cancer
Kidney cancer
Prostate cancer
Testicular cancer
Partial nephrectomy
Robotic kidney surgery
Retroperitoneal surgery
IVC surgery advanced in kidney cancers
Special Interests: 
Role for partial nephrectomy
Immunotherapy for bladder, prostate and kidney cancers
Robotic simulation
Board Certification: 
Urology, American Board of Urology
Tumor Immunotherapy Program, Dartmouth College, Hanover, NH
Klinikum Lippe-Detmold, Detmold, Germany
Dartmouth-Hitchcock Medical Center, Lebanon, NH
Education and Training: 
MD - Medizinische Hochscule Hannover, Hannover, Germany
PhD - Medizinische Hochscule Hannover, Hannover, Germany